Global Human Papillomavirus (HPV) Testing Markets to 2027 - The US Accounts for Over 29.5% of Global Market Size in 2020.

M2 PRESSWIRE-July 6, 2020-: Global Human Papillomavirus (HPV) Testing Markets to 2027 - The US Accounts for Over 29.5% of Global Market Size in 2020

(C)1994-2020 M2 COMMUNICATIONS

RDATE:06072020

The "Human Papillomavirus (HPV) Testing - Global Market Trajectory & Analytics"

report has been added to ResearchAndMarkets.com's

offering.

Global Human Papillomavirus (HPV) Testing Market to Reach US$1.1 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Human Papillomavirus (HPV) Testing estimated at US$708.1 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 6.2% over the period 2020-2027.The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 5.8% CAGR for the Period of 2020-2027The Human Papillomavirus (HPV) Testing market in the U.S. is estimated at US$209 Million in the year 2020. The country currently accounts for a 29.51% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$189.3 Million in the year 2027 trailing a CAGR of 5.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR while Rest of European market (as defined in the study) will reach US$189.3 Million by the year 2027.We bring years of research experience to this 6th edition of the report. The 108-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others:Abbott LaboratoriesAgilent Technologies, Inc.Arbor Vita CorporationBecton, Dickinson & CompanyCepheid, Inc.Daan Gene Co. Ltd.Diagcor...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT